# Surface Oncology, Inc.

Surface Oncology, Inc. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** Surface Oncology, Inc.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001718108

## About

Surface Oncology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001718108, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2023-03-09, it reported annual revenue of USD 30,000,000; net income of USD -63,586,000; total assets of USD 159,910,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $30.0M (USD 30,000,000)
- **Net income:** -$63.6M (USD -63,586,000)
- **Total assets:** $159.9M (USD 159,910,000)
- **Cash and equivalents:** $50.9M (USD 50,910,000)
- **Operating cash flow:** -$59.6M (USD -59,552,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $2.7M (USD 2,687,000)
- **Net income:** -$78.5M (USD -78,485,000)
- **Total assets:** $190.8M (USD 190,847,000)
- **Cash and equivalents:** $56.0M (USD 56,045,000)
- **Operating cash flow:** -$62.3M (USD -62,344,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $126.2M (USD 126,162,000)
- **Net income:** $59.3M (USD 59,337,000)
- **Total assets:** $217.1M (USD 217,138,000)
- **Cash and equivalents:** $175.1M (USD 175,141,000)
- **Operating cash flow:** $30.0M (USD 29,997,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $15.4M (USD 15,360,000)
- **Net income:** -$54.8M (USD -54,789,000)
- **Total assets:** $131.7M (USD 131,693,000)
- **Cash and equivalents:** $46.8M (USD 46,755,000)
- **Operating cash flow:** -$60.1M (USD -60,140,000)
- **Later filings:** Revenue: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2023-09-08 — period 2023-09-08 — 8-K
- Form 8-K — filed 2023-08-30 — period 2023-08-30 — 8-K
- Form 10-Q — filed 2023-08-02 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-08-02 — period 2023-08-02 — 8-K
- Form SC 13G — filed 2023-07-20 — SC 13G
- Form 8-K — filed 2023-07-10 — period 2023-07-06 — 8-K
- Form 8-K — filed 2023-07-03 — period 2023-06-30 — 8-K
- Form 8-K — filed 2023-06-16 — period 2023-06-15 — 8-K
- Form 10-Q — filed 2023-05-04 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-04 — period 2023-05-04 — 8-K
- Form 10-K/A — filed 2023-05-01 — period 2022-12-31 — 10-K/A
- Form 10-K — filed 2023-03-09 — period 2022-12-31 — 10-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/surface-oncology-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology